CVE-2025-64778: Mirion Medical EC2 Software NMIS BioDose · Use of Hard-coded Credentials
Affects Mirion Medical EC2 Software NMIS BioDoseSource CVE Database V5
Not known to be exploited · CVSS 8.4 High.
Data as of 26 Oct 2026, 14:05 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 1% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 2 Dec 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Mirion Medical EC2 Software NMIS BioDose | Affected
| Fixed in– |
AI-suggested
Organizations should immediately audit their NMIS BioDose deployments to identify affected versions and binaries containing hard-coded credentials. Until patches are released, restrict local access to trusted personnel only and monitor for unusual access patterns or privilege escalations. Employ application-layer controls such as multi-factor authentication and network segmentation to limit exposure. Replace hard-coded credentials with secure credential management solutions, such as environment variables or encrypted vaults, once vendor patches or updates become available. Conduct thorough code reviews and binary analysis to detect embedded secrets in custom or legacy software components. Implement strict logging and alerting for access to the NMIS BioDose application and database. Engage with Mirion Medical for timelines on official patches and apply them promptly. Additionally, ensure compliance with data protection regulations by encrypting sensitive data at rest and in transit and maintaining incident response plans tailored to medical device software vulnerabilities.
Description
CVE-2025-64778 is a high-severity vulnerability in Mirion Medical's EC2 Software NMIS BioDose (version 22.02 and earlier) caused by hard-coded plaintext passwords embedded in executable binaries. These credentials can be exploited by attackers with low privileges and no user interaction to gain unauthorized access to the application and its database, potentially compromising confidentiality and integrity. The vulnerability does not require network-level access but local access, limiting remote exploitation. No known exploits are currently reported in the wild. European organizations using this software in medical or radiation monitoring contexts face risks of data breaches and operational disruption. Mitigation requires removing hard-coded credentials, implementing secure credential storage, and applying vendor patches once available. Countries with significant healthcare infrastructure and usage of Mirion Medical products, such as Germany, France, and the UK, are most likely affected. Given the high CVSS score (8.4) and potential impact on sensitive medical data, immediate remediation is advised.